Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Akebia Therapeutics, Inc. | 948,432 | reported | 02 Feb 2026 | tx 42+3,347,100−303,268 |
| Protara Therapeutics, Inc. | 26,332 | reported | 15 Mar 2019 | tx 30+581,336−190,655 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | SALE | Akebia Therapeutics, Inc. | 25,375 | 1.39 USD | |
| 02 Feb 2026 | SALE | Akebia Therapeutics, Inc. | 21,582 | 1.39 USD | |
| 02 Feb 2026 | SALE | Akebia Therapeutics, Inc. | 20,701 | 1.39 USD | |
| 30 Jan 2026 | GRANT_AWARD | Akebia Therapeutics, Inc. | 204,000 | 0.00 USD | |
| 30 Jan 2026 | GRANT_AWARD | Akebia Therapeutics, Inc. | 320,000 | 0.00 USD | deriv |
| 03 Mar 2025 | SALE | Akebia Therapeutics, Inc. | 7,144 | 1.83 USD | |
| 03 Feb 2025 | SALE | Akebia Therapeutics, Inc. | 23,270 | 2.10 USD | |
| 03 Feb 2025 | SALE | Akebia Therapeutics, Inc. | 27,236 | 2.10 USD | |
| 31 Jan 2025 | GRANT_AWARD | Akebia Therapeutics, Inc. | 194,900 | 0.00 USD | |
| 31 Jan 2025 | GRANT_AWARD | Akebia Therapeutics, Inc. | 292,300 | 0.00 USD | deriv |
| 25 Aug 2023 | SALE | Akebia Therapeutics, Inc. | 27,000 | 1.15 USD | |
| 29 Feb 2024 | SALE | Akebia Therapeutics, Inc. | 7,169 | 1.58 USD | |
| 27 Feb 2024 | SALE | Akebia Therapeutics, Inc. | 8,367 | 1.52 USD | |
| 01 Feb 2024 | SALE | Akebia Therapeutics, Inc. | 24,311 | 1.68 USD | |
| 31 Jan 2024 | GRANT_AWARD | Akebia Therapeutics, Inc. | 202,200 | 0.00 USD | |
| 31 Jan 2024 | GRANT_AWARD | Akebia Therapeutics, Inc. | 303,300 | 0.00 USD | deriv |
| 16 May 2023 | SALE | Akebia Therapeutics, Inc. | 63,567 | 1.07 USD | |
| 01 Mar 2023 | SALE | Akebia Therapeutics, Inc. | 1,110 | 0.88 USD | |
| 01 Mar 2023 | SALE | Akebia Therapeutics, Inc. | 6,400 | 0.88 USD | |
| 01 Mar 2023 | SALE | Akebia Therapeutics, Inc. | 6,613 | 0.88 USD | |
| 27 Feb 2023 | SALE | Akebia Therapeutics, Inc. | 7,539 | 0.81 USD | |
| 31 Jan 2023 | GRANT_AWARD | Akebia Therapeutics, Inc. | 196,200 | 0.00 USD | |
| 31 Jan 2023 | GRANT_AWARD | Akebia Therapeutics, Inc. | 294,300 | 0.00 USD | deriv |
| 31 Aug 2022 | SALE | Akebia Therapeutics, Inc. | 1,147 | 0.36 USD | |
| 12 May 2022 | GRANT_AWARD | Akebia Therapeutics, Inc. | 200,000 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 20 Nov 2019.